News | Page 49 | Englander Institute for Precision Medicine

Multicolored ribbon and people graphic signifiy rare diseases, to raise awareness on Rare Disease Day in February. Credit: Shutterstock

National Organization for Rare Disorders Designates Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center as a Rare Disease Center of Excellence

September 7, 2023

Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center have together been named a Rare Disease Center of Excellence by the National Organization for Rare Disorders (NORD). The designation adds the academic medical center to NORD’s collaborative network of 40 participating...

A New Targeted Treatment Shows Promise for Select Patients with Stomach Cancer

August 23, 2023

An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, extended survival for patients with advanced gastric or gastroesophageal junction cancer that overexpressed a specific biomarker.

Results from the GLOW study, published...

In this illustration, hematopoiesis (blood cell formation) is depicted as a tree limb and branches.

Severe COVID-19 Can Alter Long-term Immune System Response

August 17, 2023

Severe COVID-19 infection triggers changes that affect gene expression in immune system stem cells, causing long-lasting alterations in the body’s immune response, according to a new study by Weill Cornell Medicine and Jackson Laboratory investigators. The finding could help explain...